Meta-Analysis of Circulating Cell-Free DNA's Role in the Prognosis of Pancreatic Cancer.

Jelena Milin-LazovicPetar MadzarevicNina RajovicVladimir DjordjevicNikola MilicSonja PavlovicNevena VeljkovicNatasa M MilicDejan Radenkovic

Published in: Cancers (2021)

The assessment of KRAS mutation by liquid biopsy can be considered as an additional tool for the estimation of the disease course and outcome in PDAC patients.

Keyphrases

systematic review
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
randomized controlled trial
meta analyses
ionic liquid
patient reported outcomes